Effects of vasoactive agents on isolated human umbilical arteries and veins.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011247:Pregnancy; D011453:Prostaglandins / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011955:Receptors, Drug; D012701:Serotonin / Q000494:pharmacology; D013268:Stimulation, Chemical; D014469:Umbilical Arteries / Q000187:drug effects*; D014471:Umbilical Veins / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology
D001593:Benzyl Compounds; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D011725:Pyridines; D011955:Receptors, Drug; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D010121:Oxytocin; D011189:Potassium Chloride; D001285:Atropine; D006632:Histamine; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine; D004837:Epinephrine